AVVAA World Health Care Products, Inc. (OTCPK: AVVH)
Health Care · Biotechnology · US
$0.00
-8.22% today · -25.9% 1Y
AVVAA World Health Care Products, Inc. (OTCPK: AVVH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.04M and employs 5 people.
Over the last twelve months the share price has lost 25.9%, trading between 0.00 and 0.01.
Tweenvest scores AVVAA World Health Care Products, Inc. across four factors: quality 0/100, value 52/100. Its strongest factor is value.
AVVH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.04M
- Revenue (TTM)
- $37.46K
- P/E
- 0.26
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 966.84M
- Employees
- 5
- Next earnings
- —
About AVVAA World Health Care Products, Inc.
AVVAA World Health Care Products, Inc. operates as a global biotechnology firm, specializing in natural and therapeutic personal care solutions. Its primary endeavor involves the development, manufacturing, and mass-market distribution of the over-the-counter Neuroskin product line. These treatments are formulated to address various skin irregularities and promote the natural clarity and texture of healthy skin, reaching consumers through conventional food and drug channels. Beyond its own brands, AVVAA also possesses distribution rights for a range of patented European skincare items. These scientifically-backed formulations target the symptoms of persistent dermatological conditions such as eczema, psoriasis, and acne. Diversifying its portfolio, the company extends its natural care offerings to animals, providing grooming treatments for a variety of pets including dogs, cats, and horses. Established in 1998 and headquartered in Richmond, Virginia, AVVAA has been a subsidiary of Gold Quest Capital, Inc. since June 23, 2021.
- ISIN
- US0024322010
- Founded
- 1998
- Listed since
- Feb 23, 2001
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $266.31 | +0.51% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $441.75 | +0.55% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.61 | +0.34% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €883.80 | -2.02% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.00 | -1.43% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.